FDAnews seeks a full-time, in-house managing editor for several hard-news, business-to-business newsletters covering the pharmaceutical and medical devices industry and the regulations affecting these companies. This person’s major responsibilities include the day-to-day management of...
Two former managers of FierceMarkets who built its life sciences vertical from a tiny email newsletter into a profitable multimillion dollar venture, have recently struck out on their own. Endpoints is producing two email newsletters per day...
Beth Kutscher, the former California bureau chief for Modern Healthcare, has been hired by LinkedIn to cover the industry. Kutscher writes, “Before I joined LinkedIn as our first healthcare news editor, I was on...
The Kansas City Business Journal is looking for a journalist who is fascinated by what will happen, not merely what has happened. Our health care/big tech beat combines coverage of the changing face of...
The Birmingham Business Journal is seeking a reporter to cover Birmingham’s huge health care community and its ever-growing technology and innovation scene. The ideal candidate will marry strong traditional journalism skills – source building,...
Arundhati Parmar has been hired as vice president and editorial director at MedCity News, an online news source covering the business of health care. Parmar writes, “I consider myself lucky to be a part of the fourth...
The health news site Stat plans to go behind a paywall by the end of the year, reports Joseph Lichterman of Nieman Lab. Lichterman writes, “A portion of the site will remain free, but Macaulay’s team...
Drug store operator Walgreen Co. has ended its relationship with blood testing company Theranos Inc., delivering another blow to the once high-flying company. Michael Siconolfi, Christopher Weaver and John Carreyrou of The Wall Street Journal had the news:...
Jared Hopkins, a reporter at the Chicago Tribune, has been hired by Bloomberg News to cover pharmaceutical companies. Hopkins had been with the newspaper since 2009 and focused on sports, including the tangling worlds of...
Merck & Co. dipped into the biotech world on Thursday, agreeing to acquire Afferent Pharmaceuticals, whose lead drug is being evaluated as a treatment for refractory, chronic cough and idiopathic pulmonary fibrosis with cough. Josh...
